Complete Genomics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

GNOM 3.14
price chart
BGI-Shenzhen Agrees to Buy Complete Genomics
Sept. 17 (Bloomberg) -- BGI-Shenzhen, a Chinese operator of genome-sequencing centers, agreed to acquire Complete Genomics Inc. for about $117.6 million to expand in the U.S. market for medical and research DNA testing. BGI will pay $3.15 a share in ...
Chinese DNA company to buy Complete Genomics  The Deal Pipeline
Chinese company agrees to buy Mountain View DNA-sequencing company ...  San Jose Mercury News
Related articles »  
Complete Genomics: A Leader In DNA Sequencing
Complete Genomics (NASDAQ:GNOM) was founded in 2005 and is headquartered in Mountain View, CA. It is an up and coming life sciences company that develops and commercializes an innovative DNA sequencing platform for complete human genome ...
Related articles »  
Illumina, Complete Genomics Settle Patent Disputes
Law360, Los Angeles (July 18, 2013, 8:04 PM ET) -- Complete Genomics Inc. and Illumina Inc. have agreed to settle all claims in two separate patent infringement cases brought by Illumina over four of its patents, without payment being made by either ...
Related articles »  
Complete Genomics chief returns fire on CFIUS warning
by William McConnell In Washington | Published December 14, 2012 at 8:25 AM Complete Genomics Inc. chairman Clifford A. Reid is firing back at thwarted suitor Illumina Inc., a rival in the genome sequencing business whose executives have predicted ...
Related articles »  
Complete Genomics, A Complete Future?
With the cost of whole-genome sequencing (WGS) rapidly declining from millions to mere thousands today, medicine is in the midst of a major revolution.
Related articles »  
Complete Genomics: Say No To The Sale - Part 2
It's tragic that Complete Genomics (NASDAQ:GNOM) is being sold for a price that you would put on to expired aspirin. Among all the chatter that has surrounded the company subsequent to the buyout announcement, no one has said that $3.15 is a fair price.
Genomes-R-Us: Is BGI now Complete?  Xconomy
Related articles »  
BGI-Shenzhen Acquires US-Based Complete Genomics For $117M
19, 2013) - BGI, a genomics company based in Shenzhen, China, has successfully acquired U.S.-based whole human genomic sequencing provider, Complete Genomics, Inc., through its wholly-owned subsidiary, Beta Acquisition Corporation. BGI completed ...
Related articles »  
Complete Genomics Says Its Probes Differ From Illumina's
Law360, San Francisco (February 20, 2013, 4:06 PM ET) -- Complete Genomics Inc. urged a California federal judge on Wednesday to rule that its genome-testing kits do not violate Illumina Inc.'s patents, arguing that it has produced enough evidence that ...
Complete Genomics' IPO Meets With Lukewarm Reception
DNA sequencing firm Complete Genomics (NASDAQ:GNOM) went public after scaling back its deal price more than 30 percent to get it done.
Is Complete Genomics, Inc. (GNOM) Going to Reward These Hedge Funds?
Complete Genomics, Inc. (NASDAQ:GNOM) was in 9 hedge funds' portfolio at the end of the fourth quarter of 2012. GNOM investors should pay attention to an increase in activity from the world's largest hedge funds lately.